| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 05:42 | Prenetics Raises $1 Billion For IM8 Via General Catalyst's Customer Value Fund | 2 | pulse2.com | ||
| Di | Prenetics Global Limited: Prenetics' IM8 Secures $1 Billion Growth Financing from General Catalyst's Customer Value Fund (CVF) | 4 | GlobeNewswire (USA) | ||
| Di | Prenetics Global Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 25.06. | Prenetics Global Limited (PRE) Receives Bullish Coverage as IM8 Targets Supplement Market Growth | 1 | Insider Monkey | ||
| 10.06. | Prenetics posts revenue growth, lifts 2026 outlook | 1 | Seeking Alpha | ||
| 10.06. | Prenetics raises 2026 IM8 revenue guidance on strong growth | 4 | Investing.com | ||
| 10.06. | Prenetics Global Limited: Prenetics Announces Record Q1 2026 Results with IM8 Revenue Reaching a Record ~$16.7 Million in May, Implying ~$200 Million in Annualized Recurring Revenue | 907 | GlobeNewswire (Europe) | Q1 2026 revenue of $36.0 million with IM8 revenue of $33.8 million, up 23.1% from IM8 revenue of $27.4 million in Q4 2025 and nearly 6x year-over-year from IM8 revenue of $5.7 million in Q1 2025Raises... ► Artikel lesen | |
| PRENETICS GLOBAL Aktie jetzt für 0€ handeln | |||||
| 04.06. | Prenetics Global Limited: Prenetics Appoints Hudson Leogrande, Founder and CEO of Multi-Billion-Dollar DTC Brand Comfrt, to Board of Directors as IM8 Accelerates TikTok and Meta Expansion | 10 | GlobeNewswire (USA) | ||
| 04.06. | Prenetics Global Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 20.05. | Prenetics Global Limited: Prenetics Announces Jay Shetty as IM8 Global Ambassador and Shareholder in Multi-Year Partnership | 6 | GlobeNewswire (USA) | ||
| 14.05. | Prenetics Global Reports Q1 2026 Results: Full Earnings Call Transcript | 4 | Benzinga.com | ||
| 14.05. | Prenetics raises 2026 guidance on IM8 supplement growth | 2 | Investing.com | ||
| 14.05. | Prenetics Global Limited: Prenetics Welcomes Brian J. Rosin as Chief Financial Officer of IM8 | 432 | GlobeNewswire (Europe) | ~ Two-decade veteran of premium consumer health, nutrition, and direct-to-consumer brands joins IM8 to support its rapid global expansion NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- Prenetics Global... ► Artikel lesen | |
| 14.05. | Prenetics Global reports Q1 results; gives Q2 and raises FY26 outlook | 3 | Seeking Alpha | ||
| 14.05. | Prenetics Global Ltd - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 07.05. | Prenetics Global Limited: Prenetics' IM8 Named Exclusive Health Supplements Partner of Inter Miami CF in Multi-Year Partnership | 2 | GlobeNewswire (USA) | ||
| 04.05. | Prenetics Global Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 14.04. | Prenetics Global Limited: Prenetics' IM8 Health Partners with Vitamin Angels to Combat Global Malnutrition, Commits to Impacting 400,000 Mothers and Children in Year One | 5 | GlobeNewswire (USA) | ||
| 02.04. | Prenetics gewinnt NBA-Star Giannis Antetokounmpo als neuen Aktionär und Partner | 5 | Investing.com Deutsch | ||
| 02.04. | Prenetics Global Limited: Prenetics Announces NBA Champion and Two-Time MVP Giannis Antetokounmpo as IM8 Global Partner and Shareholder in Multi-Year Partnership | 2 | GlobeNewswire (USA) |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| REGENERON PHARMACEUTICALS | 571,90 | -0,47 % | Attovia files for IPO to take on Sanofi and Regeneron's Dupixent | ||
| VIKING THERAPEUTICS | 33,250 | 0,00 % | Viking Therapeutics: 48 Prozent in einem Monat - Novo-Nordisk-Konkurrent dreht wieder auf | Die Erfolge von Novo Nordisk und Eli Lilly haben dazu geführt, dass viele Biopharma-Unternehmen in die Adipositas-Forschung eingestiegen sind. Viking Therapeutics hingegen widmet sich schon länger metabolischen... ► Artikel lesen | |
| CANSINO BIOLOGICS | 2,700 | +3,05 % | CanSino Biologics Inc: CanSinoBIO's MCV4 Receives Registration Approval in Argentina, Further Expanding International Presence in South America | HONG KONG, June 29, 2026 - (ACN Newswire) - On June 25, CanSino Biologics Inc. (SSE: 688185, HKEX: 06185) announced that the Company's ACYW135 Meningococcal Polysaccharide Conjugate Vaccine (CRM197)... ► Artikel lesen | |
| GUARDANT HEALTH | 143,30 | +2,23 % | Weekly Buzz: Guardant Health, Eli Lilly Gain FDA Nod; Teva Pharmaceutical, GSK, Lead M&A Wave; Zealand Pharma, Eli Lilly Post Strong Data | NEW BRUNSWICK (dpa-AFX) - This week, the biotech sector saw a surge of FDA, EU, and China approvals spanning oncology, dermatology, autoimmune and rare disease indications. Strategic acquisitions... ► Artikel lesen | |
| SINO BIOPHARM | 0,576 | +0,68 % | COPD-Forschung: AstraZeneca greift zu: Milliardenchance mit neuem Lungenmedikament? | © Foto: CFOTO - picture alliance / CFOTOAstraZeneca sichert sich die Exklusivrechte außerhalb Chinas an einem COPD-Wirkstoff. Der Deal kann auf bis zu 1,9 Milliarden US-Dollar anwachsen.AstraZeneca... ► Artikel lesen | |
| BIO-TECHNE | 62,44 | +0,16 % | Übernahme durch Merck: RBC Capital stuft Bio-Techne herab | ||
| INNOVENT BIOLOGICS | 10,724 | +6,03 % | Spero Therapeutics, Inc.: Spero Therapeutics and Innovent Biologics Announce Exclusive License for SP001 (IBI355), a Phase 2-Ready Third-Generation Anti-CD40L Antibody | Under the terms of the agreement, Spero will receive exclusive global rights, excluding Greater China, to develop, research, manufacture, and commercialize SP001 (IBI355) Innovent will receive an... ► Artikel lesen | |
| GENSCRIPT BIOTECH | 1,640 | +1,86 % | GENSCRIPT BIO (01548): VOLUNTARY ANNOUNCEMENT: LEGEND ANNOUNCES PRELIMINARY SALES FOR CARVYKTI FOR THE QUARTER ENDED 30 JUNE 2026 | ||
| QUANTUM-SI | 0,880 | +1,59 % | Quantum-Si Incorporated: Quantum-Si Announces the Start of the Proteus Roadshow | Multi-city Roadshow To Drive Awareness of Proteus and Develop Customer Funnel for Commercial Launch Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics... ► Artikel lesen | |
| SCILEX | 7,600 | -0,65 % | Scilex Holding Company Announces Dream Bowl I Meme Coin Tokens Commence Trading on the Biconomy Exchange on July 6, 2026 | PALO ALTO, Calif., July 06, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company ("Scilex" or the "Company") (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing, and... ► Artikel lesen | |
| AKESO | 11,595 | +8,21 % | Akeso, Inc.: Phase II Trial of Cadonilimab (PD-1/CTLA-4) Combination Regimen Launches in the United States for Perioperative Treatment of Gastric Cancer | HONG KONG, July 14, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that it has entered into a collaboration with Memorial... ► Artikel lesen | |
| ORIGIN AGRITECH | 0,885 | +4,12 % | Origin Agritech LTD - 6-K, Report of foreign issuer | ||
| HARMONY BIOSCIENCES | 34,590 | -0,63 % | Wall Street Analysts See a 27.35% Upside in Harmony Biosciences (HRMY): Can the Stock Really Move This High? | ||
| QIAGEN | 36,800 | +1,56 % | Dax legt zu - Qiagen-Aktien gefragt | Frankfurt/Main - Am Donnerstag hat der Dax zugelegt. Zum Xetra-Handelsschluss wurde der Index mit 25.118 Punkten berechnet, ein Plus in Höhe von 0,9 Prozent im Vergleich zum Vortagesschluss. Nach einem... ► Artikel lesen | |
| EVOTEC | 3,486 | -7,04 % | KI Abverkauf geht weiter: DAX: Hält die 25.000? Traton, Vossloh und Evotec im Fokus | © Foto: KI-generiert mit DALL-E Schlechte Vorgaben aus den USA und Asien dürften den DAX heute wieder mit der Marke von 25.000 Punkten kämpfen lassen. Die Lage zwischen den USA und dem Iran eskaliert... ► Artikel lesen |